Evidence map›Paper›PMID 28344926›Full record

ArticleCurrent opinion in chemical engineering2016

Mechanotransduction in cancer.

LiKang Chin, Yuntao Xia, Dennis E Discher, Paul A Janmey

Abstract read
In one paragraph

Article in Current opinion in chemical engineering, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed.

  1. Nanomechanical Hallmarks ofInternational journal of molecular sciences · 2021
    Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. An active matter model captures spatial dynamics of actomyosin oscillations in larval epithelial cells duringProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

LiKang ChinDepartment of Physiology and the Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA 19104, USA; Physical Sciences in Oncology Center at Penn (PSOC@Penn), University of Pennsylvania, Philadelphia, PA 19104, USA; Clinical Research Center for Diabetes, Tokushima University Hospital, Tokushima 770-8503, Japan.
Yuntao XiaPhysical Sciences in Oncology Center at Penn (PSOC@Penn), University of Pennsylvania, Philadelphia, PA 19104, USA; Molecular & Cell Biophysics and NanoBioPolymers Labs, University of Pennsylvania, Philadelphia, PA 19104, USA.
Dennis E DischerPhysical Sciences in Oncology Center at Penn (PSOC@Penn), University of Pennsylvania, Philadelphia, PA 19104, USA; Molecular & Cell Biophysics and NanoBioPolymers Labs, University of Pennsylvania, Philadelphia, PA 19104, USA.
Paul A JanmeyPhysical Sciences in Oncology Center at Penn (PSOC@Penn), University of Pennsylvania, Philadelphia, PA 19104, USA; Clinical Research Center for Diabetes, Tokushima University Hospital, Tokushima 770-8503, Japan.

Funding

PSOC@Penn Education and OutreachU54CA193417 · NCI · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2015 to 2020
$10.5M
Pathological consequences of altered tissue mechanics in fibrosisR01EB017753 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A, SHENOY, VIVEK · 2014 to 2025
$6.3M
Nanoscience of 'Self' - reductionist approaches to hCD47 inhibition of phagocytesR01HL124106 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2014 to 2022
$3.1M
Nuclear Mechanics varies with Tissue Mechanics & Regulates CytoskeletonR21HL128187 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI DISCHER, DENNIS E. · 2015 to 2016
$426k
NCI NIH HHS U54 CA193417NHLBI NIH HHS R01 HL124106NHLBI NIH HHS R21 HL128187NIBIB NIH HHS R01 EB017753
6 · The paper itself

Abstract

Tissue stiffness is tightly controlled under normal conditions, but changes with disease. In cancer, tumors often tend to be stiffer than the surrounding uninvolved tissue, yet the cells themselves soften. Within the past decade, and particularly in the last few years, there is increasing evidence that the stiffness of the extracellular matrix modulates cancer and stromal cell mechanics and function, influencing such disease hallmarks as angiogenesis, migration, and metastasis. This review briefly summarizes recent studies that investigate how cancer cells and fibrosis-relevant stromal cells respond to ECM stiffness, the possible sensing appendages and signaling mechanisms involved, and the emergence of novel substrates - including substrates with scar-like fractal heterogeneity - that mimic the

Identifiers

PMID28344926
PMCPMC5362117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.